Beyond the Bench

Innovation and technology is at the heart of personalized healthcare and DevSci remains committed to discovering and utilizing new technologies and approaches to drug development that not only deepens our knowledge of existing medicines, but informs the development of future treatments. Click below to learn more about the innovative efforts happening within DevSci.

Machine Learning

Automating Quality Assessment of Mass Spectrometry Peaks Using Machine Learning
Advanced Analytics

Predicting Risk for Drug-Induced Liver Injury (DILI) for Small Molecule Therapeutics
Virtual Trial

Alternative Regimens for Approved Treatments without Clinical Trials
Internal Collaborations

Machine Learning: Detecting Tumors in Mouse Models of Lung Cancer
External Collaborations

Predicting an Immune Response in Patients
Simulating Virtual Trials

Getting Label Claims Approved by Simulating Virtual Trials Instead of Running Clinical Trials
Quantitative Pharmacology

Quantitative Pharmacology to Broaden the Therapeutic Window of Mosunetuzumab to Enhance Benefit/Risk

Leveraging Real World Data

Leveraging Real World Data (RWD) to Accelerate Drug Development
Ipatasertib CDx Development

Ipatasertib CDx Development

Close Bitnami banner
Bitnami